Opposite, binary regulatory pathways involved in IL-i-mediated stromelysin gene expression in rat mesangial cells. Glomerular mesangial cells express matrix metalloproteinase stromelysin in response to the proinflammatory cytokine IL-lp. The present study was conducted to identify intracellular machinery involved in this IL-i action, especially focusing on the role of the TPA response element (TRE) located in the 5'-fianking region of the stromelysin gene. Using transient transfection with a pTRE-LacZ reporter plasmid, we detected no obvious up-regulation of TRE activity in rat mesangial cells following the IL-i stimulation.
cells express matrix metalloproteinase stromelysin in response to the proinflammatory cytokine IL-lp. The present study was conducted to identify intracellular machinery involved in this IL-i action, especially focusing on the role of the TPA response element (TRE) located in the 5'-fianking region of the stromelysin gene. Using transient transfection with a pTRE-LacZ reporter plasmid, we detected no obvious up-regulation of TRE activity in rat mesangial cells following the IL-i stimulation.
However, the basal activity of TRE was found to be essential to the stromelysin induction, since (i) mesangial cells stably expressing a transdominant negative mutant of c-Jun, which effectively suppressed both basal and inducible TRE activity, exhibited the blunted expression of stromelysin in response to IL-l/3, whereas (ii) transfection with a c-fos antisense gene, which suppressed only the inducible TRE activity, did not affect the stromelysin induction. To seek cooperative pathways required for the IL-i action, we next focused on protein kinases, the potential regulators of the stromelysin gene. Stimulation of mesangial cells with a protein kinase C (PKC) activator, phorbol 12-myristate 13-acetate (PMA), induced the stromelysin transcript without affecting TRE activity. Depletion of intracellular PKC by high-dose PMA or inhibition of PKC activity with calphostin C suppressed the stromelysin induction by iL-1, suggesting the crucial contribution of a PKC-mediated, but TRE-independent pathway. in contrast, either cAMP inducer forskolin or dibutyryl cAMP suppressed the IL-i-mediated stromelysin expression. An inhibitor of cAMP-dependent protein kinase A (PKA), HA1004, enhanced the IL-I effect in a dose-dependent manner. Unexpectedly, the inhibitory action of PKA was not through cAMP response element (CRE) but through TRE, because (i) activation of CRE was not induced by IL-lp, and (ii) cAMP-mediated activation of PKA suppressed the basal TRE activity. These findings elucidated the unique, binary regulation of stromelysin by IL-113; that is, IL-i up-regulated the transcript via the PKC-dependcnt pathway under the cooperation with constitutively active TRE, and this stimulatory effect was in part counterbalanced by the IL-i-inducible PKA which down-regulated the basal TRE activity.
Matrix metalloproteinases (MMPs) have been implicated in various pathophysiological conditions such as wound healing, bone remodeling, arthritis and tumor invasion/metastasis [1] . In the glomerulus, certain types of MMP are constitutively expressed and, conceivably, participate in the normal turnover of mesangial matrix and basement membrane [2, 3] . In pathological situations glomerular MMPs are often up-regulated, and the accelerated matrix breakdown may contribute to destruction of glomerular architecture as well as to abnormal behavior of glomerular cells [4] [5] [6] . Several mediators, especially inflammatory cytokines, induce MMPs in glomerular cells. For example, mesangial cells abundantly express MMP-9 (gelatinase B) and stromelysin (transin) in response to the pro-inflammatory cytokine IL-lp [2, 7, 8] . However, currently little is understood about intracellular events involved in the cytokine-mediated induction of MMPs in mesangial cells. We recently reported that expression of MMP-9 by IL-ip is regulated through c-Jun/activator protein-i (AP-i) and tyrosine kinase-nuclear factor-KB (NF-KB) pathways [8] . In this report, we aimed to address signal transduction systems involved in the expression of another IL-i-inducible MMP, stromelysin.
The 5 '-flanking region of the stromelysin gene is known to contain a 12-o-tetradecanoylphorbol-13-acetate (TPA) response element (TRE), the binding site of AP-i [9] . AP-1 is a family of transcription factors composed of dimeric Jun and/or Fos. These homodimers or heterodimers bind to TRE and up-regulate transcription. In mesangial cells, IL-i induces c-jun and c-fos [8, 10] and thereby have the potential for activation of TRE. In this study, we first examined whether or not the activation of TRE is associated with the up-regulation of stromelysin by IL-lp.
Protein kinase C (PKC) is known to be activated by IL-i in several cell types [11, 12] . This molecule is a crucial regulator of AP-1 and involved in growth factor-mediated induction of stromelysin in fibroblasts [13] . Although in mesangial cells induction of MMP-9 and monocyte chemoattractant protein-i by IL-i is independent of PKC [8, 14] , we next examined the role of this protein kinase in the IL-i-mediated stromelysin induction. During the course of the study, we found that a non-specific protein kinase inhibitor enhanced the stromelysin induction by IL-1f3. We speculated that a certain protein kinase might counteract against the up-regulation of stromelysin by IL-113. To elucidate the molecules responsible for this negative regulation, the focus became cAMP-dependent protein kinase (protein kinase A; PKA), since cAMP is induced by IL-I in some cell types [111 and may be a potential suppressor of cytokine/oncogeneinducible stromelysin expression [15-i7] . cAMP is generated by membrane-associated adenylate cyciase and induces activation of PKA. Activated PKA modulates the function of a nuclear factor, cAMP response element modulator (CREM), which binds to the cAMP response element (CRE), and thereby initiates transcription [18] . Although CRE is not located in the 5'-regulatory region of the stromelysin gene [iS], the cAMP-PKA pathway triggered by Yokoo Using genetic and pharmacological modulators for signaling molecules, this study demonstrates the opposite, binary regulatory pathways involved in IL-i-mediated stromelysin expression in rat mesangial cells. TRE is the crucial target for the dual regulation. Basal activity of TRE contributes to the stromelysin induction under the cooperation with PKC, and this stimulatory pathway is in part counteracted by the IL-i-inducible PKA via down-regulation of the basal TRE activity.
Methods

Mesangial cells
Rat mesangial cells were established from isolated glomeruli of an adult male Sprague-Dawley rat (body weight 200 g), as described previously [19] . Since cultured mesangial cells may contain heterogeneous populations, we established a cell clone SM43 by a limiting dilutional method and identified as being of mesangial cell phenotype as described [201. Cells were maintained in Dulbecco's MEM/F-12 (DME-F12; GIBCO BRL, Gaithersburg, MD, USA) supplemented with 100 U/mI penicillin G, 100 jig/ml streptomycin, 0.25 ig/ml of amphotericin B, and 10% fetal calf serum (FCS; GIBCO BRL). DME-F12 containing 1% FCS was generally used as a basal culture medium for assays.
A transfected mesangial cell clone, JUNDN1, which stably expresses a transdominant negative mutant of c-Jun, was generated as follows. TAM-67 is a deletion mutant which is lacking amino acids 3 to 122 of c-Jun [211. The protein encoded by this truncated Jun gene retains the DNA binding and leucine zipper domains but lacks the transactivating domain. Overexpression of TAM-67, therefore, inhibits AP-1-mediated transactivation via blocking formation or binding of functional AP-1 complexes in a transdominant negative fashion [211. Using a modified calcium phosphate co-precipitation method, SM43 cells (5 >< 10) were co-transfected with 10 tg of pCMV-TAM67 [22] encoding the mutated c-jun and 1 jg of pRc/CMV (Invitrogen, San Diego, CA, USA), which introduces a neomycin phosphotransferase gene, as described before [5] . Stable transfectants were selected in the presence of neomycin analogue G418 (0.75 mg/mI; Sigma, Dorset, UK). Expression of the transgene was confirmed by Northern blot analysis, and JUNDNI was established.
An expression plasmid pH/3F0sAS-neo that introduces an antisense c-fos was constructed by subcloning of the BamHI-SalI fragment of c-fos from p75'15 [23] into the SalI-BamHl sites of pHApr-1-neo [24] in an antisense orientation. SM43 mesangial cells were transfected with 10 .tg of the pHI3F0sAS-neo, selected by G418, and a stable transfectant FOSAS1 was established.
Efficient inactivation of AP-1 in these established transfectants was confirmed by evaluating TRE activity using transient transfection with a TRE reporter plasmid, as described below. The functional specificity of the transdominant negative mutant of c-Jun in JUNDN1 cells was also investigated by evaluating the NF-KB activation in response to IL-lp [8] . For this purpose, a KB reporter plasmid pHIVLTRI3-gal [25] was utilized. This construct introduces a bacterial p-galactosidase gene (lacZ) under the control of a human immunodeficiency virus (HIV) promoter which contains two KB motifs. With a calcium phosphate coprecipitation method, JUNDN1 cells and mock transfectants cultured in 24-well culture plates (1.5 X i0 cells/well) were transiently transfected with pHIVLTR-gal (80 ng/well) or a control plasmid pmuHIVLTRj3-gal, which contains a KB-mutated HIV promoter. After 48 hours, cells were stimulated by IL-lp (5 ng/ml, human recombinant; Otsuka Pharmaceutical Co, Ltd., Tokushima, Japan) for 24 hours and subjected to X-gal (5-bromo-4-chloro-3-indolyl f3-o-galactopyranoside; Sigma) assay [20] to detect p-galactosidase activity. This is described in detail below.
Pharmacological manipulation
To investigate the action of IL-1j3, confluent mesangial cells were incubated in 1% FCS/DME-F12 for 48 hours and exposed to 5 ng/ml of IL-1J3 for 24 hours. The role of PKC was investigated by stimulating the cells with a PKC activator phorbol 12-myristate 13-acetate (PMA; 30 ng/ml, Sigma) for 24 hours, or by pretreating with high-dose PMA (300 ng/ml; 24 hr) or a specific PKC inhibitor, calphostin C (250 to 500 nM; 3 hr; Calbiochem-Novabiochem Ltd., Nottingham, UK), prior to the IL-i stimulation [8] .
To examine the role of the cAMP-PKA pathway, cells were pretreated with a c-AMP inducer forskolin (1 to 10 pvi; ICN Pharmaceuticals Ltd., Oxfordshire, UK), a cAMP analogue N6,2'-o-dibutyryladenosine 3':S'-cyclic monophosphate (dibutyryl cAMP; 50 to 100 M, Sigma), or a PKA inhibitor N-(2-guanidinoethyl)-5-isoquinoline sulfonamide (HA1004; ito 10 M, Sigma) for 1.5 hours and then stimulated by IL-lp.
Assessment of TRE and CRE activities
To evaluate the activity of TRE and CRE, reporter plasmids pTRE-LacZ and pCRE-LacZ [26] were utilized, as described previously [8, 27] . These constructs introduce lacZ under the control of TRE or CRE so that the activity of each response element can be monitored via ,!3-galactosidase expression. Mesangial cells cultured in 24-well culture plates (1.5 X i0 cells/well) were transiently transfected with each plasmid (80 ng/well) using the calcium phosphate co-precipitation method and, after 72 hours, subjected to X-gal assay to detect p-galactosidase activity [20] . In brief, cells were fixed in 0.5% glutaraldehyde, 2 mM MgC12, and 1.25 mM EGTA in PBS for 15 minutes and incubated at 37°C for two hours in a reaction buffer containing 1 mg/mI X-gal, 20 m'vi K3Fe(CN)6, 20 mM K4Fe(CN)( 3H20, 2 mM MgCI2, 0.01% sodium desoxycholate, and 0.02% NP-40 in PBS. The activity of TRE and CRE was assessed by counting blue cells stained by X-gal under the field of a light microscope. In some experiments, the cells transfected with the reporter plasmids were stimulated by IL-lp for 24 hours prior to X-gal assay.
To examine the TRE activity in stably transfected mesangial cells, a pharmacological stimulator of AP-1/TRE, pyrrolidine dithiocarbamate (PDTC, Sigma), was used [27, 28] . Untransfected cells, JUNDN1 or FOSAS1 were treated with or without 50 gtvi PDTC for 24 hours, and TRE activity was assessed by transient transfection with pTRE-LacZ, as described above. To exclude the influence of clonal variability in transfection efficiency, the number of X-gal-positive cells in each group was normalized by the number of X-gal-positive cells transfected with a control expression plasmid pCXL [29] . All the transfection experiments were performed in quadruplicate.
Northern blot analysis Total RNA was extracted by a single-step method [301, and Northern blot analyses were performed as described before [31] . The RNA samples (10 jLg/lane) were electrophoresed on 1.2% agarose gels and transferred onto nitrocellulose membranes (Schleicher & Shuell, Dassel, Germany). For the hybridization, each probe was labeled with 32P-dCTP using a random priming method. The membranes were hybridized with probes at 65°C overnight in a solution containing 4 X SSC (600 mivi NaCI, 60 mM sodium citrate), 5x Denhardt's solution, 10% dextran sulfate, 50 jrg/ml herring sperm DNA and 50 j.rg/ml poly (A) washed four times in 4 X SSC/0.1% SDS at 50°C and exposed to Kodak XAR films at -80°C. A rat stromelysin eDNA [321, a human c-fos eDNA [131, and a mutated human c-jun cDNA [211 were used as probes.
Statistical analysis
All experiments were repeated two to four times, and representative results are shown. Data were expressed as means SE. Statistical analysis was performed using the two sample t test to compare data in different group of cells. A P value less than 0.05 was used to indicate a statistically significant difference.
Results
Contribution of AP-1 and TRE IL-1 has an ability to induce c-jun and c-fos in SM43 mesangial cells [1 To elucidate the role of AP-1 and TRE in the induction of stromelysin by IL-lp, we first examined the TRE activity in mesangial cells under both unstimulated and IL-I-stimulated conditions. Transient transtection with a reporter plasmid revealed that TRE was constitutively active in unstimulated mesangial cells mainteined in the basal assay medium containing 1% FCS (Fig. 1) . This was defined as "basal TRE activity." This basal activity was not affected by IL-1/3 [92.7 3.7% versus unstimulated state (100%), mean sEl whereas it was significantly up-regulated by the AP-1 stimulator, PDTC (147.6 7.6% vs. control, P < 0.05). This result suggested that additional activation of TRE is not required for the induction of stromelysin by IL-1/3.
To confirm this further, the stable transfectant FOSAS1 was utilized. This mesangial cell clone expressed 2.5 kb mRNA corresponding to the antisense transcript of c-fos ( Fig. 2A) .
Transient transfection study with a pTRE-LacZ plasmid revealed that the expressed antisense gene did not affect the basal TRE activity, but markedly suppressed the PDTC-inducible TRE activation (Fig. 2B) . Compared to mock transfected cells, 78.6 7 .1% of inducible TRE activity was abrogated by the transfection with the c-fos antisense gene. Using this transfectant, induction of stromelysin by IL-lp was examined. Northern blot analysis showed no obvious alteration in the expression levels of stromelysin in FOSAS1 cells compared to mock transfectants (Fig. 2C) . This finding further supported the above result that additional activation of TRE is not involved in the IL-i-mediated stromelysin induction.
Under the basal culture condition, cultured rat mesangial cells express c-jun but not c-fos [8, 27] . The homodimer of c-Jun conceivably contributes to the basal TRE activity [33] . To examine whether the basal activity of TRE is required for the IL-i action, we utilized JUNDN1 cells stably expressing a transdominant negative mutant of c-Jun. Northern blot analysis showed that the JUNDN1 expressed 0.9 kb of a transgene transcript (Fig. 3A) . Transient transfection assay revealed that the expressed mutant gene was functional, since TRE activity was significantly repressed under both unstimulated and PDTC-stimulated conditions (Fig.  3B ). The TRE activity was reduced to 72.4 3.4% in unstimulated state and to 45.6 3.5% in the PDTC-stimulated condition compared with the values of mock transfected cells (100%, P < 0.05). The suppressive action of the transgene was restricted to TRE, since as shown in Figure 3C , activation of the KB site triggered by IL-113 was unaffected in JUNDNI cells; that is, that, compared to mock transfectants, the stromelysin expression was markedly suppressed in the JUNDN1 cells (Fig. 3D ). These data indicated that basal activity of TRE is essential to the stromelysin induction by IL-1/3.
Involvement of PKC
Basal activity of TRE was found to be required but insufficient for the induction of stromelysin. Some other signaling pathways should cooperatively contribute to the IL-i action. To seek the complementary pathways required, we next focused on PKC, the potential regulator of the stromelysin gene [13, 161 . Stimulation of mesangial cells with a PKC activator PMA induced stromelysin transcript (Fig. 4A) . Furthermore, depletion of PKC by high-dose PMA suppressed the stromelysin induction by IL-1f3. The crucial contribution of PKC was also confirmed by an another pharmacological inhibitor caiphostin C. This agent inhibited the IL-i induction of stromelysin in a dose-dependent manner (Fig. 4B) . Interestingly, PMA-mediated PKC activation did not affect the TRE activity (Fig. 4C) . These data suggested that, without affecting TRE, IL-i -induced PKC cooperated with some housekeeping pathway that maintained the basal TRE activity and, thereby, induced stromelysin transcription. 
Role of PK4
The role of cAMP-responsive PKA in IL-i-mediated stromelysin expression was investigated because cAMP is induced by IL-i irs some cell types [11] and may be a potential suppressor of cytokine/oncogene-inducible stromelysin expression [15] [16] [17] . Mesangial cells were pretreated with a cAMP inducer forskolin or dibutyryl cAMP and stimulated by IL-1f3. Northern blot analysis revealed that both agents effectively suppressed the stromelysin induction in a dose-dependent manner (Fig. 5 A, B) . To examine whether the cAMP-PKA pathway is activated by IL-i and modulates the stromelysin expression, mesangial cells were pretreated with a PKA inhibitor HA1004 and then stimulated by IL-1f3. As shown in Figure SC , HAl 004 enhanced the expression of stromelysin dose dependently. Under the unstimulated condition, HAl 004 alone had no impact on the stromelysin expression (data not shown). These findings suggested that PKA was implicated in the IL-i action as a negative regulator of stromelysin gene expression.
Generally, cAMP-dependent PKA regulates target gene transcription via CRE. We therefore examined the effect of IL-1/3 on the activity of CRE using transient transfection with a reporter plasmid pCRE-LacZ. Under the unstimulated condition, mesangial cells exhibited no CRE activity ( There is a substantial sequence homology between TRE and CRE [341. It has been reported that CRE binding proteins (CREB) may have an ability to bind to TRE and inhibit its activation [35] . To investigate whether TRE is the target of the PKA action, the effect of dibutyryl cAMP on the basal activity of TRE was tested in the presence or absence of the PKA inhibitor HA1004. Transfection with pTRE-LacZ elucidated that dibutyryl cAMP significantly reduced the basal activity of TRE [53.9 3.3% vs. control (100%); Fig. 6B ]. In the presence of HA1004, however, this reduction was abolished. These findings elucidated the unique binary regulation of stromelysin by IL-1/3; that is, the basal TRE activity required for the IL-I action was, in part, down-regulated by the IL-i-inducible PKA.
Discussion
In this report, we describe the opposite, binary regulatory pathways involved in IL-i-mediated stromelysin gene expression in rat mesangial cells. We showed that IL-1/3 up-regulated stromelysin via the PKC-dependent pathway under the cooperation with constitutively active TRE. Interestingly, this stimulatory effect was found to be, in part, counterbalanced by the IL-i-inducible PKA which down-regulated the basal TRE activity. A schematic summary of our results is shown in Figure 7 .
To examine the role of AP-1 in the IL-i action, we established stable transfectants, FOSAS1 and JUNDNI. FOSAS1 stably expressing the antiscnse transcript of c-fos showed repressed TRE activity exclusively under the stimulated condition. in contrast, JUNDN1, which expresses the transdominant negative mutant of c-Jun, exhibited attenuated TRE activity under both basal and stimulated conditions. This difference is possibly due to the fact that rat mesangial cells express c-jun but not c-fos in the basal culture condition [8, 271 . The basal activity of TRE in mesangial cells is thus maintained by c-Jun/AP-1 constitutively expressed in response to serum components or some autocrine mediators, as reported in other cell types 1331 JUNDN1 exhibited a blunted induction of stromelysin responding to IL-1f3, whereas the response in FOSAS1 was unaffected. These findings, together with the fact that IL-13 did not up-regulate the TRE activity, indicated that the basal TRE activity is required but its additional activation is not necessary for the induction of stromelysin by lL-lp. This is similar to the mechanism involved in TPA-mediated stromelysin induction in human libroblasts and tumor cell lines [36, 37] .
Since the basal activity of TRE is insufficient for the induction of stromelysin, sonic other pathways should cooperatively mediate the IL-I action. We identified that the PKC-depcndent but TRE-independent pathway is one of the essential contributors. In mesangial cells, the role of PKC in the IL-I signaling is little understood [101. Generally, IL-i stimulates mesangial cells through PKC-independent pathways [8, 10, 14, 38] . However, in this study, we elucidated the crucial contribution of PKC, based on the data that (i) PKC activation induced stromelysin gene expression and (ii) depletion or inhibition of intracellular PKC mechanism involved in the PKC-dependent but TRE-independent regulatory pathway.
In this study, we found that IL-i induction of stromelysin by the PKC-and TRE-mediated pathways was, in part, counterbalanced by the IL-i-inducible PKA. This is because either forskolin or dibutyryl cAMP suppressed the stromelysin induction, and a PKA inhibitor enhanced the IL-i action dose dependently. This finding is in agreement with a previous report in human synovial fibroblasts [16] . Unexpectedly, however, the inhibitory effect of PKA was not through CRE but via attenuation of the basal TRE activity that is essential to the stromelysin induction. The mechanism involved in this phenomenon is unkown. One possibility may he direct modulation of TRE by CRE-accessible transacting molecules. A substantial sequence homology has been reported between TRE and CRE [34] . Both cAMP response element modulator (CREM) and CRE binding proteins (CREB) that structurally resemble Fos and Jun have an ability to bind to TRE and, thereby, may inhibit its activation [35] . This evidence implies that PKA-inducible nuclear factors could directly inhibit TRE activity and counteract against the stromelysin expression triggered by the positive regulatory pathways.
IL-1f3 induces c-fos and c-jun in mesangial cells [8] , and therefore, the activity of TRE should be up-regulated. However, in this study, the activity of TRE was unaffected following the IL-i or PMA stimulation. This is similar to the case of NIH3T3 fibroblasts that exhibit substantial levels of basal TRE activity and insensitivity to PMA-mediated activation of TRE [44] . A possible explanation for this may be that IL-I-inducible PKA acted as a for induction of stromelysin by PKC activators [37, 41] ; and (iii)
Ets is up-regulated by PKC as well as by tyrosine kinases [41] [42] [43] .
Ets proteins induced by PKC and/or tyrosine kinases could, therefore, mediate the effect of IL-1f3 demonstrated here. Interestingly, AP-1 complexes interact with c-Ets-i and function as accessory molecules to achieve Ets-dependent transcriptional activation [44] . This protein-protein interaction could explain the iL-I /3 up-regulates stromelysin transcription via the PKC-dependent pathway under the cooperation with constitutively active TRE. This stimulatory effect is in part counterbalanced by the IL-I-inducible PKA which down-regulates the basal TRE activity. negative regulator via CREM or CREB and counterbalanced the increase in TRE activity. The lack of CRE activation by IL-1/3 in the presence of activated PKA could also be explained by such a cross-coupling of transacting molecules between TRE and CRE [34] . Further investigation will be required to clarify these issues.
In summary, we demonstrated the unique binary regulatory system involved in the IL-i-mediated stromelysin expression in mesangial cells. Although the pathophysiological relevance of this opposing dual control is unclear, the negative regulatory pathway identified here could function as a "stopper" that restrains the excessive responses of mesangial cells to proinflammatory stimuli within the nephritic microenvironment. 
